About Nanz Med Science Pharma Private Limited
Data last updated: 18 December 2025
Nanz Med Science Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 19 December 2006, the company has been in operation for over 20 years.
Registered with ROC Delhi under CIN U01403DL2006PTC156756.
Capital: an authorised share capital of ₹15 Cr and a paid-up capital of ₹12.11 Cr. It is led by directors including Manmit Singh Malhotra and Harpreet Singh Puri.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: C – 168 Ground Floor, Naraina Industrial Area Phase I, New Delhi, Delhi, India – 110028.
As per the financials filed for FY 2025, the company reported a revenue of ₹258.64 Cr, a growth of 10% compared to the previous year.
The company has a workforce of approximately 450 employees as per the latest available data.
The company is associated with 1 brand - Nanz Medscience Pharma. As per MCA filings, the company has open charges of ₹105.15 Cr and satisfied charges of ₹46.5 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nanzpharma.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered AddressC – 168 Ground Floor, Naraina Industrial Area Phase I, New Delhi, Delhi, India – 110028
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Nanz Med Science Pharma Private Limited
Nanz Med Science Pharma Private Limited has one previous CIN (Corporate Identification Number): U01403DL2006PTC156756. The current CIN is U24100DL2006PTC156756, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100DL2006PTC156756 | Current |
| U01403DL2006PTC156756 | Previous |
Associated Brands with Nanz Med Science Pharma Private Limited
Nanz Med Science Pharma Private Limited operates one associated brand: Nanz MedScience Pharma. These brands represent Nanz Med Science Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Provides contract-based pharmaceutical formulation research, manufacturing, and marketing services. | nanzpharma.com |
Competitors & Alternatives of Nanz Med Science Pharma Private Limited
Brands and companies operating in the same space as Nanz Med Science Pharma Private Limited include Pharmaron, Pfizer, Lonza and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Pharmaron
|
Drug discovery and development services for small molecules are provided. | Beijing, China, China | 2003 |
Pfizer
|
Pharmaceutical products for treating multiple diseases are provided. | New York, United States, United States | 1849 |
Lonza
|
CDMO services for pharma, biotech, and specialty ingredients are provided. | Basel, Switzerland, Switzerland | 1897 |
Dotmatics
|
AI powered scientific data management and workflow automation solutions | - | 2005 |
Boehringer Ingelheim
|
Generic drugs and clinical research services are provided globally. | - | 1885 |
LabConnect
|
Laboratory testing, clinical trial research, and biopharma services are provided. | Johnson City, United States, United States | 2002 |
Beta Drugs
|
Developer of therapeutics for oncology and dermatology | Panchkula, India, India | 2005 |
Ainos
|
Novel point-of-care testing and low-dose interferon therapeutics are developed. | San Diego, United States, United States | 1986 |
Biomatter
|
Provider of synthetic biology and AI-based technology for generative protein design | Vilnius, Lithuania, Lithuania | 2018 |
Business Activity of Nanz Med Science Pharma Private Limited
Nanz Med Science Pharma Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Nanz Med Science Pharma Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Nanz Med Science Pharma Private Limited
Nanz Med Science Pharma Private Limited is currently managed by 4 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manmit Singh Malhotra | Managing Director | 01 Apr 2009 | 17 Years 3 Months | Current |
| Harpreet Singh Puri | Additional Director | 15 Nov 2024 | 1 Years 8 Months | Current |
| Sunpreet Kaur Puri | Additional Director | 15 Nov 2024 | 1 Years 8 Months | Current |
| Lakhvinder Pal Singh | Director | 01 Oct 2007 | 18 Years 9 Months | Current |
Financials of Nanz Med Science Pharma Private Limited FY 2024 filings available
Nanz Med Science Pharma Private Limited reported revenue of ₹258.64 Cr (up 10.00% YoY) for FY 2025.
Ten-year financial statements for Nanz Med Science Pharma Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nanz Med Science Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2025 | Hdfc Bank Limited | ₹8.5 Lakh | Open |
| 23 Dec 2024 | Others | ₹6 Cr | Open |
| 15 Jan 2024 | Hdfc Bank Limited | ₹28.08 Lakh | Open |
| 18 Dec 2023 | Tata Capital Financial Services Limited | ₹3 Cr | Open |
| 15 Nov 2023 | Hdfc Bank Limited | ₹44 Lakh | Open |
Total charge records: 16 View all charges
Employees and EPFO Compliance at Nanz Med Science Pharma Private Limited
View historical data on people associated with Nanz Med Science Pharma Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Nanz Med Science Pharma Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Nanz Med Science Pharma Private Limited
GST registrations and filing compliance for Nanz Med Science Pharma Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Nanz Med Science Pharma Private Limited
Credit ratings, litigation, and regulatory alerts for Nanz Med Science Pharma Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nanz Med Science Pharma Private Limited
MSME payment history for Nanz Med Science Pharma Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nanz Med Science Pharma Private Limited
Corporate group structure for Nanz Med Science Pharma Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nanz Med Science Pharma Private Limited
MCA filings and documents for Nanz Med Science Pharma Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Nanz Med Science Pharma Private Limited
Frequently Asked Questions about Nanz Med Science Pharma Private Limited
Nanz Med Science Pharma Private Limited is an active private limited company in the pharma sector based in New Delhi, Delhi, India. It was incorporated on 19 December 2006 (20+ years old) and is registered under CIN U24100DL2006PTC156756. The company has 450 employees.
Nanz Med Science Pharma Private Limited reported revenue of ₹258.64 Cr for FY 2025 (up 10.00% YoY).
The current directors of Nanz Med Science Pharma Private Limited are:
- Manmit Singh Malhotra - Managing Director
- Harpreet Singh Puri - Additional Director
- Sunpreet Kaur Puri - Additional Director
- Lakhvinder Pal Singh - Director
The primary industry of Nanz Med Science Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Nanz Med Science Pharma Private Limited can be reached at the registered office: C – 168 Ground Floor, Naraina Industrial Area Phase I, New Delhi, Delhi, India – 110028, or through the website nanzpharma.com.
The authorised capital is ₹15 Cr, and the paid-up capital is ₹12.11 Cr.